ENDRA Life Sciences (NDRA) Return on Sales (2016 - 2018)
Historic Return on Sales for ENDRA Life Sciences (NDRA) over the last 3 years, with Q4 2018 value amounting to 1586.7%.
- ENDRA Life Sciences' Return on Sales fell 12517100.0% to 1586.7% in Q4 2018 from the same period last year, while for Dec 2018 it was 1586.7%, marking a year-over-year decrease of 15714000.0%. This contributed to the annual value of 106.08% for FY2024, which is 842300.0% down from last year.
- Latest data reveals that ENDRA Life Sciences reported Return on Sales of 1586.7% as of Q4 2018, which was down 12517100.0% from 746.72% recorded in Q3 2018.
- Over the past 5 years, ENDRA Life Sciences' Return on Sales peaked at 3.11% during Q2 2016, and registered a low of 1586.7% during Q4 2018.
- For the 3-year period, ENDRA Life Sciences' Return on Sales averaged around 318.96%, with its median value being 25.52% (2017).
- Within the past 5 years, the most significant YoY rise in ENDRA Life Sciences' Return on Sales was -14700bps (2018), while the steepest drop was -12517100bps (2018).
- ENDRA Life Sciences' Return on Sales (Quarter) stood at 1.34% in 2016, then plummeted by -24971bps to 334.98% in 2017, then crashed by -374bps to 1586.7% in 2018.
- Its last three reported values are 1586.7% in Q4 2018, 746.72% for Q3 2018, and 26.25% during Q2 2018.